Beijing Beilu Pharmaceutical Co.,Ltd. Posted 4.2 Million Yuan Net Loss in First Three Quarters of 2023

Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陆药业股份有限公司) (300016.SZ) reported a net loss of 4.2 million yuan in the first three quarters of 2023, reversing a net profit of 42.2 million yuan for the same period in the previous year.

Meanwhile, the company posted 649.8 million yuan in revenue, up 16.6% year-on-year.

At the end of the reporting period, it had 2.9 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 34.3%.